Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Eli Lilly ( NYSE: LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass ...

Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...

Shares of Hims & Hers closed 5.1% higher after the company said it will expand its weight-loss offerings with branded ...

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings ...

Eli Lilly introduced Mounjaro, also known as Zepbound, in India for the management of obesity and diabetes. JM Financial is bullish on the weight-loss drug's success in India, citing its price ...

American pharmaceutical giant Eli Lilly is considering manufacturing its weight-loss drug Mounjaro in India. CEO David Ricks disclosed the potential move during his visit to the country.

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

Eli Lilly may look at manufacturing its weight-loss drug Mounjaro in India in future as it expands its global footprint, CEO David Ricks, who is visiting the country, has said. His comments come ...

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs ...

US pharmaceutical giant Eli Lilly has launched Mounjaro (tirzepatide) in India, targeting the country’s $150 billion weight-loss market. This move comes as India faces a rising diabetes crisis, with ...